Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), remains a significant cause of morbidity and mortality worldwide, despite the availability of a live attenuated vaccine and anti-TB antibiotics. The vast majority of individuals infected with M. tuberculosis develop an asymptomatic latent infection in which the bacterium survives within host-generated granulomatous lesions in a physiologically altered metabolic state of nonreplicating persistence. The granuloma represents an adverse environment, as M. tuberculosis is exposed to various stressors capable of disrupting the essential constituents of the bacterium. In Gram-negative and Gram-positive bacteria, resistance to cell envelope stressors that perturb the plasma membrane is mediated in part by proteins comprising the phage shock protein (Psp) system. PspA is an important component of the Psp system; in the presence of envelope stress, PspA localizes to the inner face of the plasma membrane, homo-oligomerizes to form a large scaffold-like complex, and helps maintain plasma membrane integrity to prevent a loss of proton motive force. M. tuberculosis and other members of the Mycobacterium genus are thought to encode a minimal functional unit of the Psp system, including an ortholog of PspA. Here, we show that Rv2744c possesses structural and physical characteristics that are consistent with its designation as a PspA family member. However, although Rv2744c is upregulated under conditions of cell envelope stress, loss of
Mycobacterium tuberculosis is the causative agent of the respiratory disease tuberculosis (TB) and is a human-specific pathogen of global importance. This bacterium is responsible for Ͼ9.6 million new cases of TB and 1.5 million deaths annually (1), ranking TB as the leading cause of death in the world due to an infectious agent, alongside HIV/AIDS. A key aspect of the M. tuberculosis life cycle is its ability to establish asymptomatic latent infections and reactivate to cause active disease and transmission to new hosts (reviewed in reference 2). During latency, M. tuberculosis exists in a state of nonreplicating persistence (NRP), a poorly understood physiological state in which the bacterium can utilize alternative carbon sources and energy-generating pathways for long-term survival within the host (3-6). While a live attenuated vaccine for TB is available (Mycobacterium bovis bacillus Calmette-Guérin [BCG]), its efficacy at preventing adult pulmonary TB and thus M. tuberculosis retransmission is highly varied (7,8). Furthermore, M. tuberculosis exhibits increased phenotypic resistance to anti-TB antibiotics during NRP (2, 9), making it more difficult to kill this organism in latently infected individuals. Therefore, new strategies and/or therapeutics are urgently needed to help eradicate TB. This will require an improved understanding of the mechanisms utilized by M. tuberculosis to persist and/or reactivate within the host.